Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07719361
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
- Locations
-
- START Los Angeles Los Angeles, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- START Midwest Grand Rapids, Michigan, United States
- START New Jersey East Brunswick, New Jersey, United States
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07581184
- Conditions
- B7H3, Castration Resistant Metastatic Prostate Cancer, Genital Diseases, +12 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Irvine, California, United States
- Biogenix Molecular, LLC Miami, Florida, United States
- BAMF Health Grand Rapids, Michigan, United States
- XCancer Omaha, Nebraska, United States
NCT06844383
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
- City of Hope Duarte, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Masonic Cancer Center Minneapolis, Minnesota, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT07103018
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +18 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT05283330
- Conditions
- Astrocytoma, Breast Cancer, Breast Diseases, +58 more
- Locations
-
- Northwestern University Robert H Lurie Medical Research Chicago, Illinois, United States
- University of Iowa Health Care Iowa City, Iowa, United States
- UK Markey Cancer Center Lexington, Kentucky, United States
- Advanced Molecular Imaging and Therapy Glen Burnie, Maryland, United States
NCT06785636
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
- Cancer and Blood Research Center Los Alamitos, California, United States
- University of Colorado Health Aurora, Colorado, United States
- Mount Sinai Medical Center Miami, Florida, United States
NCT07451795
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Fujian Cancer Hospital Fujian, China
- Fudan University Shanghai Cancer Center Shanghai, China
- Fudan University Shanghai Cancer Center Xiamen Branch Xiamen, China
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
NCT06190899
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Centre Jean Perrin Clermont-Ferrand, France
- Institut Paoli-Calmettes Marseille, France
- Centre Antoine Lacassagne Nice, France
NCT07192120
- Conditions
- Advanced Malignant Solid Tumor, mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06801236
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
- University of California San Diego, Moores Cancer Center La Jolla, California, United States
- Moffitt Cancer Center, Tampa Tampa, Florida, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Harvard Medical School-Massachusetts General Hospital Boston, Massachusetts, United States
Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity
NCT07302763
- Conditions
- Neoplasms, mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Locations
-
- CHU de Québec-Université Laval Québec, Quebec, Canada
NCT06702995
- Conditions
- Metastatic Castrate-resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Locations
-
- Cancer Hosipital of Shandong First Medical University,440 Jiyan Road, Jinan City, Shandong Province Jinan, Shandong, China
- 270 Dongan Road, Shanghai Shanghai, Shanghai Municipality, China
Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer
NCT07623460
- Conditions
- mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Locations
-
Not specified
Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC
NCT06768255
- Conditions
- Abiraterone Acetate, mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Pudong New Area, China